OncLive Announces 2013 “Giants of Cancer Care”

Press Release
Published Online: Friday, July 26, 2013
Oncology Luminaries Selected by Peers for Prestigious National Honor

PLAINSBORO, N.J. -- OncLive today announced the 2013 “Giants of Cancer Care,” 12 luminaries selected by oncology industry peers for their remarkable achievements in research and/or clinical practice. The inaugural Giants of Cancer Care awards recognize and celebrate individuals who have achieved landmark success within the field of oncology.

The Giants program is presented by OncLive, the official website for Oncology & Biotech News, OncologyLive, Urologists in Cancer Care, Oncology Nursing News, and Contemporary Oncology. Giants are organized by specialty and chosen by an exclusive advisory panel of oncology educators, clinicians and researchers.

OncLive Chairman and CEO Mike Hennessy said, “We’re proud to honor these exemplary members of the oncology profession. These ‘Giants’ have dedicated their lives to improving the quality and quantity of life for cancer patients. Our enormous gratitude is the foundation of this program.”

In evaluating criteria for selection to the inaugural class of Giants, the Advisory Panel considered “pioneers,” characterized by individuals who have amassed a large body of work and have already accomplished their most notable contributions to oncology; and separately, “innovators,” those who recently (within approximately the past 10 years) have made a significant contribution to patient care, clinical trials or translational research.

The 2013 Giants of Cancer Care

Breast: Bernard Fisher, M.D., University of Pittsburgh

Pioneer in the biology and treatment of breast cancer

Gastrointestinal: Bert Vogelstein, M.D., Johns Hopkins Medicine

Pioneer who discovered the molecular basis of colorectal cancer

Genetics: Elizabeth H. Blackburn, Ph.D., University of California, San Francisco

Innovator in the genetic composition and function of telomeres

Genitourinary: Lawrence H. Einhorn, M.D., Indiana University

Pioneered a life-saving treatment for testicular cancer

Head & Neck: Everett E. Vokes, M.D., University of Chicago

Innovator of concomitant chemoradiation therapy for head and neck cancers

Leukemia: Brian J. Druker, M.D., Oregon Health & Sciences University

Innovator of targeted therapies for chronic myeloid leukemia

Lung: Thomas J. Lynch, Jr., M.D., Yale Cancer Center

Pioneered the use of molecular testing for EGFR mutations in lung cancer

Lymphoma: Vincent T. DeVita, Jr., M.D., Yale Cancer Center

Innovator of combination chemotherapy regimens for large-cell lymphomas

Melanoma: Steven A. Rosenberg, M.D., National Institutes of Health

Pioneered adoptive immunotherapy in melanoma

Myeloma: Robert A. Kyle, M.D., Mayo Clinic

Pioneer in myeloma research, treatment and education

Prostate: Charles L. Sawyers, M.D., Memorial Sloan-Kettering Cancer Center

Innovator of novel androgen-receptor inhibitor for treatment of advanced prostate cancer

Scientific Advances: Judah Folkman, M.D., Harvard Medical School (deceased)

Pioneer and Father of angiogenesis

The 2013 Giants of Cancer Care will be acknowledged at an invitation-only reception Friday, July 26 at the Hyatt Regency in Huntington Beach, California. Each Giant will be individually profiled in a November 2013 special edition of OncologyLive and prominently featured on OncLive.com.

Online CME Activities
Free CME from PER
Cancer Summaries and Commentaries: Update from Chicago – Skin Cancer and Other Cutaneous Malignancies
Oncology Briefing: Advances in Estrogen Receptor-Positive Breast Cancer
Coping With Confidence: Online Clinical Case Discussions
OncoLogue: Cases in Follicular Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma
More Reading
Publications
$auto_registration$